LENALIDOMIDE TREATMENT IN 5Q(-) SYNDROME: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Uskudar, H. Teke [1 ]
Andic, N. [1 ]
Gunduz, E. [1 ]
Ozpolat, S. [2 ]
Aras, B. Durak [2 ]
Akay, O. [1 ]
机构：
[1] Eskisehir Osmangazi Univ, Fac Med, Hematol, Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Fac Med, Genet, Eskisehir, Turkey
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30198-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
197
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [31] Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q
    Gohring, Gudrun
    Lange, Kathrin
    Hofmann, Winfried
    Nielsen, Kirsten Vang
    Hellstrom-Lindberg, Eva
    Roy, Lydia
    Morgan, Michael
    Kreipe, Hans
    Buesche, Guntram
    Giagounidis, Aristoteles
    Schlegelberger, Brigitte
    BLOOD, 2010, 116 (21) : 18 - 18
  • [32] The role of lenalidomide in the management of myelodysplasia with del 5q
    Kelaidi, Charikleia
    Eclache, Virginie
    Fenaux, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (03) : 267 - 278
  • [33] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
  • [34] Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide
    Beier, Fabian
    Kharabi Masouleh, Behzad
    Buesche, Guntram
    Ventura Ferreira, Monica S.
    Schneider, Rebekka K.
    Ziegler, Patrick
    Wilop, Stefan
    Vankann, Lucia
    Gattermann, Norbert
    Platzbecker, Uwe
    Giagounidis, Aristoteles
    Goetze, Katharina S.
    Nolte, Florian
    Hofmann, Wolf-Karsten
    Haase, Detlef
    Kreipe, Hans
    Panse, Jens
    Blasco, Maria A.
    Germing, Ulrich
    Bruemmendorf, Tim H.
    LEUKEMIA RESEARCH, 2015, 39 (11) : 1292 - 1298
  • [35] The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes
    Melchert, Magda
    Kale, Vishakha
    List, Alan
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 123 - 129
  • [36] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome With Isolated Del(5q) With Lenalidomide, Bortezomib, and Dexamethasone
    Washington, Nyomi R.
    Shippey, Eugen A.
    Osswald, Michael
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [37] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome with Isolated Del(5q) with Lenalidomide, Bortezomib, and Dexamethasone
    Washington, Nyomi
    Shippey, Eugen A., III
    Osswald, Michael B.
    BLOOD, 2020, 136
  • [38] Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion
    Chesnais, Virginie
    Renneville, Aline
    Toma, Andrea
    Lambert, Jerome
    Passet, Marie
    Dumont, Florent
    Chevret, Sylvie
    Lejeune, Julie
    Raimbault, Anna
    Stamatoullas, Aspasia
    Rose, Christian
    Beyne-Rauzy, Odile
    Delaunay, Jacques
    Solary, Eric
    Fenaux, Pierre
    Dreyfus, Francois
    Preudhomme, Claude
    Kosmider, Olivier
    Fontenay, Michaela
    BLOOD, 2016, 127 (06) : 749 - 760
  • [39] Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report
    Furukawa, Haruna
    Nomura, Jun
    Kobayashi, Masahiro
    Abe, Shori
    Takeda, Tomoki
    Oka, Yumiko
    Shirota, Yuko
    Kodera, Takao
    Okitsu, Yoko
    Takahashi, Shinichiro
    Murakami, Keigo
    Kameoka, Junichi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 259 (02): : 113 - 119
  • [40] Changes Associated With Lenalidomide Treatment in the Gene Expression Profiles of Patients With Del(5q)
    Belickova, Monika
    Cermak, Jaroslav
    Merkerova, Michaela Dostalova
    Vesela, Jitka
    Krejcik, Zdenek
    Cechova, Eliska
    Zemanova, Zuzana
    Michalova, Kyra
    Votavova, Hana
    Caniga, Miroslav
    Neuwirtova, Radana
    Jonasova, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (05): : 375 - 383
12345